GLP‐1RA vs placebo
Worsening kidney function · CVD (ASCVD, HF, or both)
GLP‐1RA may leads to lower worsening renal function compared with placebo (low certainty).
1 finding from 1 review
- Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2… 2021 · Cochrane Headline outcomes onlyOR 0.61 [0.44, 0.84]1 study · 3297 participantsLow